Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Non-Current Assets (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Other Non-Current Assets for 8 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 29.66% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 29.66% year-over-year, with the annual reading at $1.8 million for FY2025, 29.66% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $1.8 million at Whitehawk Therapeutics, down from $2.0 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.3 million in Q1 2022, with the low at $20000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $1.7 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets surged 11585.0% in 2022, then decreased 25.03% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $2.2 million in 2021, then fell by 1.58% to $2.2 million in 2022, then fell by 14.33% to $1.9 million in 2023, then fell by 25.03% to $1.4 million in 2024, then grew by 29.66% to $1.8 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $1.8 million, $2.0 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.